Lipocine (NASDAQ:LPCN) Coverage Initiated by Analysts at Sto

StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Up 1.4 % Shares of LPCN opened at $5.08 on Friday. Lipocine has a 12 month low of $3.30 and […]

Related Keywords

Maheshv Patel , , Lipocine Inc , Renaissance Technologies , Goldman Sachs Group Inc , Lipocine Company Profile , Blackrock Inc , Millennium Management , Free Report , Get Free Report , Street Corp , Goldman Sachs Group , Sachs Group , Lipocine Daily , Lipocine , Nasdaq Lpcn , Lpcn , Medical , Initiated Coverage , Stocknews Com ,